Background: Aluminium-containing phosphate binders have long been used for treatment of hyperphosphatemia in dialysis patients. Their safety became controversial in the early 1980's after reports ...

By 1970 the administration of aluminium hydroxide and/or calcium carbonate as phosphate binders in dialysis patients was virtually universal practice. In 1972, Alfrey was one of the first to ...

A recent study has investigated the effect of phosphate binder choice on the risk of death in hemodialysis patients. All-cause mortality was assessed in 127 patients new to hemodialysis who had ...

In chronic kidney disease (CKD), the calcium–PTH–vitamin ... In addition, we discuss the effects of newer phosphate binders and calcium-receptor agonists on the future application of vitamin ...

Hyperphosphatemia is linked to increased mortality risk. Dialysis patients often face a high daily pill burden, with phosphate binders making up about 50% of the total. Nonadherence to phosphate ...

To insert a central venous catheter in patients with an eGFR 30 mL/min particularly to eliminate gadolinium and to follow up with dialysis does ... free phosphate binders such as sevelamer or ...

Hyperphosphatemia is linked to increased mortality risk. Dialysis patients often face a high daily pill burden, with phosphate binders making up about 50% of the total. Nonadherence to phosphate ...

Hyperphosphatemia is linked to increased mortality risk. Dialysis patients often face a high daily pill burden, with phosphate binders making up about 50% of the total. Nonadherence to phosphate ...

Dialysis patients often face a high daily pill burden, with phosphate binders making up about 50% of the total. Nonadherence to phosphate binders is a significant challenge contributing to ...

In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Unicycive Therapeutics (UNCY – Research Report), with a ...